$20B Trade Vision to Expand India-Brazil Economic Ties
India and Brazil have advanced their long-standing strategic partnership by formalizing several agreements spanning technology, energy, mining, healthcare, and trade. This renewed cooperation underscores their joint commitment to strengthening economic relations, reinforcing resilient supply chains, and improving coordination among Global South countries.
Both nations have also set a target of exceeding $20 billion in bilateral trade by 2030, highlighting their determination to expand collaboration across critical sectors.
A key result of the talks was a thorough digital collaboration centered on cutting-edge technologies including blockchain, semiconductors, digital public infrastructure, artificial intelligence, and supercomputing.
Brazil intends to create a Center of Excellence for Digital Public Infrastructure, demonstrating the two countries' common goal of leveraging technology to promote sustainable growth and inclusive development.
Also Read: Piyush Goyal Urges Exporters to Utilize Free Trade Agreements
Indian and Brazil also signed agreements related to rare earth elements and critical minerals. The objective is to safeguard strategic supply chains necessary for renewable energy and advanced manufacturing industries.
Also Read: India is Seeking New Steel Export Markets in the Middle East and Asia
Energy cooperation also is another key pillar, with both countries agreeing to work together in hydrocarbons, renewable energy, ethanol blending, and sustainable aviation fuels. Brazil’s outlook on promoting biofuels aligns with a shared commitment toward climate action and cleaner energy transitions.
Also Read: AI Healthcare Breakthroughs at India AI Impact Summit 2026
Both parties signed agreements to improve access to reasonably priced medications, regulatory alignment, and pharmaceutical cooperation in the healthcare industry. Along with encouraging the sharing of traditional pharmaceuticals, the collaboration will concentrate on vaccinations, oncology therapies, rare disease medications, and innovative healthcare systems.